Close Menu

NEW YORK ─ Veravas said this week that it has received CE marking for its suite of in vitro diagnostic interference detection and mitigation products, enabling clinical use in research, laboratories, hospitals, and other healthcare settings in Europe and other geographies that accept such designation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.